# Urovant Sciences Ltd. (UROV)

Source: https://www.quantisnow.com/company/UROV
Generated: 2026-11-18T01:16:47.515Z

- Ticker: UROV
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2018

## Latest UROV news and filings

- 2022-03-07 16:56 UTC [Urovant Sciences Announces Positive Topline Results of Phase 2a Trial of its Potential Novel Gene Therapy, URO-902](https://www.quantisnow.com/insight/urovant-sciences-announces-positive-topline-results-of-phase-2a-trial-2532625)
- 2021-12-20 17:11 UTC [Urovant Sciences Announces Publication in Advances in Therapy of Analyses of Patient-Perceived Meaningfulness of Improvement in Symptom Reduction for Overactive Bladder Patients Treated with GEMTESA® (vibegron) 75 mg](https://www.quantisnow.com/insight/urovant-sciences-announces-publication-in-advances-in-therapy-of-analyses-2164270)
- 2021-11-08 13:00 UTC [Urovant Sciences Announces Publication in Blood Pressure Monitoring of Positive Ambulatory Blood Pressure Study Results for GEMTESA® (vibegron) 75 mg in Overactive Bladder Patients](https://www.quantisnow.com/insight/urovant-sciences-announces-publication-in-blood-pressure-monitoring-of-positive-1972987)
- 2021-04-08 20:08 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-urovant-sciences-ltd-601654)
- 2021-04-01 04:15 UTC [SEC Form EFFECT filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-urovant-sciences-ltd-575301)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: E. Bryan Smith disposed to the issuer $0 worth of Common Shares (124,447 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-e-bryan-smith-disposed-to-the-issuer-572293)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Sef Kurstjens disposed to the issuer $0 worth of Common Shares (21,480 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-sef-kurstjens-disposed-to-the-issuer-0-572292)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: M. James Hindman disposed to the issuer $0 worth of Common Shares (9,000 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-m-james-hindman-disposed-to-the-issuer-572291)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Cornelia Haag-Molkenteller disposed to the issuer $0 worth of Common Shares (141,348 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-cornelia-haag-molkenteller-disposed-to-the-issuer-0-572290)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Ajay Bansal disposed to the issuer $0 worth of Common Shares (140,098 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-ajay-bansal-disposed-to-the-issuer-0-572289)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Pierre Legault disposed to the issuer $0 worth of Common Shares (21,480 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-pierre-legault-disposed-to-the-issuer-0-572288)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Jr. A. James Robinson disposed to the issuer $0 worth of Common Shares (8,385 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-jr-a-james-robinson-disposed-to-the-572287)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Walt Johnston disposed to the issuer $0 worth of Common Shares (109,139 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-walt-johnston-disposed-to-the-issuer-0-572286)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: S Myrtle Potter disposed to the issuer $0 worth of Common Shares (21,480 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-s-myrtle-potter-disposed-to-the-issuer-572284)
- 2021-03-31 16:30 UTC [SEC Form 4] [SEC Form 4: Christine Ocampo disposed to the issuer $0 worth of Common Shares (78,781 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-christine-ocampo-disposed-to-the-issuer-0-572283)
- 2021-03-30 16:12 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-urovant-sciences-ltd-566296)
- 2021-03-29 21:20 UTC [SEC Form SC 13E3/A filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-urovant-sciences-ltd-562559)
- 2021-03-29 19:12 UTC [SEC Form S-8 POS filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-urovant-sciences-ltd-561711)
- 2021-03-29 19:08 UTC [SEC Form S-8 POS filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-urovant-sciences-ltd-561708)
- 2021-03-29 19:05 UTC [SEC Form S-8 POS filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-urovant-sciences-ltd-561704)
- 2021-03-29 19:03 UTC [SEC Form POS AM filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-urovant-sciences-ltd-561696)
- 2021-03-29 12:44 UTC [SEC Form 25-NSE filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-urovant-sciences-ltd-560364)
- 2021-03-29 12:35 UTC [SEC Form 8-K] [Urovant Sciences Ltd. filed SEC Form 8-K: Completion Of Acquisition Or Dispositive Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws, Other Events, Financial Statements And Exhibits](https://www.quantisnow.com/insight/urovant-sciences-ltd-filed-sec-form-8-k-completion-of-acquisition-560327)
- 2021-03-29 12:00 UTC [Sumitovant Biopharma Completes Acquisition of Urovant Sciences Sumitovant Biopharma](https://www.quantisnow.com/insight/sumitovant-biopharma-completes-acquisition-of-urovant-sciences-sumitovant-biopharma-560107)
- 2021-03-24 20:29 UTC [SEC Form 8-K] [SEC Form 8-K filed by Urovant Sciences Ltd.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-urovant-sciences-ltd-549548)
- 2021-02-23 21:10 UTC [Public Offering] [Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results](https://www.quantisnow.com/insight/hercules-capital-reports-fourth-quarter-and-full-year-2020-financial-results-423768)
- 2021-02-19 11:08 UTC [SEC Form SC 13E3/A filed](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-413161)
- 2021-02-19 11:03 UTC [SEC Form DEFM14A filed](https://www.quantisnow.com/insight/sec-form-defm14a-filed-413137)
- 2021-02-16 20:38 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-401211)
- 2021-02-12 22:01 UTC [SEC Form 10-Q filed](https://www.quantisnow.com/insight/sec-form-10-q-filed-392276)
- 2021-02-12 21:10 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-390967)
- 2021-02-12 21:05 UTC [Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results](https://www.quantisnow.com/insight/urovant-sciences-provides-merger-update-and-reports-third-quarter-fiscal-390741)
- 2021-02-11 13:05 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-381545)
- 2021-02-11 13:00 UTC [Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety Monitoring Board ](https://www.quantisnow.com/insight/urovant-sciences-announces-progression-of-uro-902-phase-2a-trial-following-381456)
- 2021-02-09 22:25 UTC [SEC Form SC 13E3/A filed](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-371243)
- 2021-02-09 22:00 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-370983)
- 2021-02-02 11:03 UTC [SEC Form PRER14A filed](https://www.quantisnow.com/insight/sec-form-prer14a-filed-338622)
- 2021-01-13 00:02 UTC [SEC Form 4: Jr. A. James Robinson disposed of $65,970 worth of Common Shares (4,095 units at $16.11), decreasing ownership by 33% to 8,385 units](https://www.quantisnow.com/insight/sec-form-4-jr-a-james-robinson-disposed-of-65970-279261)
- 2021-01-08 23:30 UTC [SEC Form 4: Cornelia Haag-Molkenteller disposed of $93,483 worth of Common Shares (5,810 units at $16.09), decreasing ownership by 4% to 141,348 units](https://www.quantisnow.com/insight/sec-form-4-cornelia-haag-molkenteller-disposed-of-93483-worth-of-270378)
- 2021-01-08 23:29 UTC [SEC Form 4: E. Bryan Smith disposed of $76,604 worth of Common Shares (4,761 units at $16.09), decreasing ownership by 4% to 124,447 units](https://www.quantisnow.com/insight/sec-form-4-e-bryan-smith-disposed-of-76604-worth-270376)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/UROV
- Earnings history: https://www.quantisnow.com/earnings/UROV
- Dividend history: https://www.quantisnow.com/dividends/UROV
- Insider transactions: https://www.quantisnow.com/insiders/UROV
- Options chain: https://www.quantisnow.com/options/UROV
- SEC 8-K filings only: https://www.quantisnow.com/company/UROV/8-k
- RSS and alerts for UROV: https://www.quantisnow.com/docs/rss-feeds.md
